Fetal overgrowth and numerous congenital malformations can be detected in every trimester of pregnancy. New technologies in molecular testing, such as chromosomal microarray analysis and next-generation sequencing, continually demonstrate advantages for definitive diagnosis in fetal life. Simpson-Golabi-Behmel (SGB) syndrome is a rare but well-known overgrowth condition that is rarely diagnosed in the prenatal setting. We report 3 cases of SGB syndrome in 2 consecutive pregnancies. In our series, distinctive prenatal sonographic findings led to molecular diagnosis. Exome sequencing from fetal DNA revealed a hemizygous splice site variant in the GPC3 gene: NM_004484.3:c.1166+ 1G>T. The mother is a heterozygous carrier. We also provide an overview of the previously published 57 prenatal cases of SGB syndrome with prevalence estimation of the symptoms to aid prenatal differential diagnosis of fetal overgrowth syndromes.

Keywords:
Fetal overgrowth, GPC3, Prenatal symptoms, Simpson-Golabi-Behmel syndrome, Ultrasound
1.
Alamillo CL, Powis Z, Farwell K, Shahmirzadi L, Weltmer EC, et al: Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies. Prenat Diagn 35:1073-1078 (2015).
2.
Alessandri JL, Cuillier F, Ramful D, Ernould S, Robin S, et al: Perlman syndrome: report, prenatal findings and review. Am J Med Genet A 146A:2532-2537 (2008).
3.
Astuti D, Morris MR, Cooper WN, Staals RH, Wake NC, et al: Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet 44:277-284 (2012).
4.
Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, et al: Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol 14:229-249 (2018).
5.
Carss KJ, Hillman SC, Parthiban V, McMullan DJ, Maher ER, et al: Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet 23:3269-3277 (2014).
6.
Chen E, Johnson JP, Cox VA, Golabi M: Simpson-Golabi-Behmel syndrome: congenital diaphragmatic hernia and radiologic findings in two patients and follow-up of a previously reported case. Am J Med Genet 46:574-578 (1993).
7.
Cottereau E, Mortemousque I, Moizard MP, Burglen L, Lacombe D, et al: Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature. Am J Med Genet C Semin Med Genet 163C:92-105 (2013).
8.
Drury S, Williams H, Trump N, Boustred C, GOSGene, et al: Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn 35:1010-1017 (2015).
9.
Eggermann T, Brioude F, Russo S, Lombardi MP, Bliek J, et al: Prenatal molecular testing for Beckwith-Wiedemann and Silver-Russell syndromes: a challenge for molecular analysis and genetic counseling. Eur J Hum Genet 24:784-793 (2016).
10.
Enns GM, Cox VA, Goldstein RB, Gibbs DL, Harrison MR, Golabi M: Congenital diaphragmatic defects and associated syndromes, malformations, and chromosome anomalies: a retrospective study of 60 patients and literature review. Am J Med Genet 79:215-225 (1998).
11.
Garavelli L, Gargano G, Simonte G, Rosato S, Wischmeijer A, et al: Simpson-Golabi-Behmel syndrome type 1 in a 27-week macrosomic preterm newborn: the diagnostic value of rib malformations and index nail and finger hypoplasia. Am J Med Genet A 158A:2245-2249 (2012).
12.
Hughes-Benzie RM, Tolmie JL, McNay M, Patrick A: Simpson-Golabi-Behmel syndrome: disproportionate fetal overgrowth and elevated maternal serum alpha-fetoprotein. Prenat Diagn 14: 313-318 (1994).
13.
Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH: Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7:245-250 (1996).
14.
Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH: First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31:493-502 (2008).
15.
Kehrer C, Hoischen A, Menkhaus R, Schwab E, Müller A, et al: Whole exome sequencing and array-based molecular karyotyping as aids to prenatal diagnosis in fetuses with suspected Simpson-Golabi-Behmel syndrome. Prenat Diagn 36:961-965 (2016).
16.
Knopp C, Rudnik-Schoneborn S, Zerres K, Gencik M, Spengler S, Eggermann T: Twenty-one years to the right diagnosis - clinical overlap of Simpson-Golabi-Behmel and Beckwith-Wiedemann syndrome. Am J Med Genet A 167A:151-155 (2015).
17.
Kucińska-Chahwan A, Bijok J, Dabkowska S, Jóźwiak A, Ilnicka A, et al: Targeted prenatal diagnosis of Pallister-Killian syndrome. Prenat Diagn 37:446-452 (2017).
18.
Kurg A, Tönisson N, Georgiou I, Shumaker J, Tollett J, Metspalu A: Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet Test 4:1-7 (2000).
19.
Kurotaki N, Imaizumi K, Harada N, Masuno M, Kondoh T, et al: Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 30:365-366 (2002).
20.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, et al: Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285-291 (2016).
21.
Li CC, McDonald SD: Increased nuchal translucency and other ultrasound findings in a case of Simpson-Golabi-Behmel syndrome. Fetal Diagn Ther 25:211-215 (2009).
22.
Lin AE, Neri G, Hughes-Benzie R, Weksberg R: Cardiac anomalies in the Simpson-Golabi-Behmel syndrome. Am J Med Genet 83:378-381 (1999).
23.
Magini P, Palombo F, Boito S, Lanzoni G, Mongelli P, et al: Prenatal diagnosis of Simpson-Golabi-Behmel syndrome. Am J Med Genet A 170:3258-3264 (2016).
24.
Mujezinović F, Krgović D, Blatnik A, Zagradišnik B, Vipotnik TV, et al: Simpson-Golabi-Behmel syndrome: a prenatal diagnosis in a foetus with GPC3 and GPC4 gene microduplications. Clin Genet 90:99-101 (2016).
25.
Neri G, Marini R, Cappa M, Borrelli P, Opitz JM: Simpson-Golabi-Behmel syndrome: an X-linked encephalo-tropho-schisis syndrome. 1988. Am J Med Genet A 161A:2697-2703 (2013).
26.
Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K: Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304:867-869 (1992).
27.
Õunap K: Silver-Russell syndrome and Beckwith-Wiedemann syndrome: opposite phenotypes with heterogeneous molecular etiology. Mol Syndromol 7:110-121 (2016).
28.
Pajusalu S, Kahre T, Roomere H, Murumets U, Roht L, et al: Large gene panel sequencing in clinical diagnostics-results from 501 consecutive cases. Clin Genet 93:78-83 (2018).
29.
Pergament E, Alamillo C, Sak K, Fiddler M: Genetic assessment following increased nuchal translucency and normal karyotype. Prenat Diagn 31:307-310 (2011).
30.
Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, et al: Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12:241-247 (1996).
31.
Richards S, Aziz N, Bale S, Bick D, Das S, et al: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405-424 (2015).
32.
Sotiriadis A, Papatheodorou S, Eleftheriades M, Makrydimas G: Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis. Ultrasound Obstet Gynecol 42:383-389 (2013).
33.
Sotos JF, Dodge PR, Muirhead D, Crawford JD, Talbot NB: Cerebral gigantism in childhood. A syndrome of excessively rapid growth and acromegalic features and a nonprogressive neurologic disorder. N Engl J Med 271:109-116 (1964).
34.
Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, et al: The Human Gene Mutation Database: 2008 update. Genome Med 1:13 (2009).
35.
Støve HK, Becher N, Gjørup V, Ramsing M, Vogel I, Vestergaard EM: First reported case of Simpson-Golabi-Behmel syndrome in a female fetus diagnosed prenatally with chromosomal microarray. Clin Case Rep 5:608-612 (2017).
36.
Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole TR, et al: Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 77:193-204 (2005).
37.
Tenorio J, Arias P, Martínez-Glez V, Santos F, Garcia-Miñaur S, et al: Simpson-Golabi-Behmel syndrome types I and II. Orphanet J Rare Dis 9:138 (2014).
38.
Vora N, Bianchi DW: Genetic considerations in the prenatal diagnosis of overgrowth syndromes. Prenat Diagn 29:923-929 (2009).
39.
Weichert J, Schröer A, Amari F, Siebert R, Caliebe A, et al: A 1 Mb-sized microdeletion Xq26.2 encompassing the GPC3 gene in a fetus with Simpson-Golabi-Behmel syndrome report, antenatal findings and review. Eur J Med Genet 54:343-347 (2011).
40.
Weksberg R, Shuman C, Beckwith JB: Beckwith-Wiedemann syndrome. Eur J Hum Genet 18:8-14 (2010).
41.
Wilkens A, Liu H, Park K, Campbell LB, Jackson M, et al: Novel clinical manifestations in Pallister-Killian syndrome: comprehensive evaluation of 59 affected individuals and review of previously reported cases. Am J Med Genet A 158A:3002-3017 (2012).
42.
Williams DH, Gauthier DW, Maizels M: Prenatal diagnosis of Beckwith-Wiedemann syndrome. Prenat Diagn 25:879-884 (2005).
43.
Yamashita H, Yasuhi I, Ishimaru T, Matsumoto T, Yamabe T: A case of nondiabetic macrosomia with Simpson-Golabi-Behmel syndrome: antenatal sonographic findings. Fetal Diagn Ther 10:134-138 (1995).
44.
Zimmermann N, Stanek J: Perinatal case of fatal Simpson-Golabi-Behmel syndrome with hyperplasia of seminiferous tubules. Am J Case Rep 18:649-655 (2017).
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.